SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NanoTechnology

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RikRichter who wrote (471)2/5/2005 3:40:16 PM
From: RikRichter  Read Replies (2) of 720
 
My mistake. The strategic partnership with SOTK and NanoBiomagnetics was being called ZetaCor, LLC not Zettacore as described in the BW article:

Sono-Tek Corporation News
September 20, 2004 - Milton, NY
NanoBioMagnetics Announces Strategic Partnership
with Sono-Tek

Edmond, OK - NanoBioMagnetics, Inc. (NBMI) has announced the formation of a new subsidiary to be called ZetaCor, LLC. The new, wholly-owned subsidiary will produce specialized nanoparticles for research and commercial applications.

At the center of ZetaCor's formation is a strategic partnership between NBMI and Sono-Tek of Milton, NY. Early in 2004, NBMI purchased from Sono-Tek one of the first SonoDry ultrasonic spray nozzle systems and is incorporating it into a full lab scale spray drying system.

"NBMI provides us with a resource that has extensive expertise in the nanoparticle industry that we have not had to date," says Dr. Chris Coccio, president and CEO of Sono-Tek Corporation. "We believe our partnership with NBMI will shorten Sono-Tek's learning curve for entering products into the nano industry, while providing NBMI unique access to a hardware manufacturer that is willing to customize machinery for their needs."

"This partnership represents a marriage of technologies," says Charles Seeney, president and CEO of NBMI. "By combining the technologies developed by Sono-Tek and NBMI, will be able to further refine the nanofabrication of unique powders and composites across a wide range of variables."

Seeney points out that the companies, individuals and institutions researching this multifaceted field have very specific requirements for their nanomaterials. NBMI currently produces magnetically responsive nanoparticles for human health applications. NBMI has moved to validation and prototype development of an organ-assisting-device (OAD) technology for hearing amplification. NBMI also is developing OAD technologies for site-specific delivery of therapeutics, currently an area of intense research interest, especially with chemotherapeutics.

"Nanotechnology research has come to the point where off-the-shelf nanomaterials are no longer sufficient," says Seeney. "There is a growing market for new, custom nanomaterials created within very narrow parameters for specialized applications. This is our forte. We have the experience and the technology to develop unique nanomaterials capable of meeting exacting standards."

For the time being, ZetaCor will share NMBI's Edmond, Oklahoma offices. However, if growth is as rapid as anticipated, ZetaCor will have its own facilities in the near future. "

For further information about NanoBioMagnetics visit their website: www.nanobmi.com.

For further information about Sono-Tek, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext